Lifecare AS (LIFE.OL) Stock Analysis & AI Equity Report
Lifecare AS (LIFE.OL) overview
Lifecare AS (LIFE.OL) stock analysis and AI equity research. For the latest completed financial year, 2025, Lifecare AS reported revenue of NOK 0.1m and operating profit of NOK -130m; the year-end share price was 0.40 NOK and market capitalisation was NOK 20.0m. Lifecare AS is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get Lifecare AS's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.
Key metrics & valuation multiples
Figures updated on 2026-05-14. Data will be refreshed during report generation.
About Lifecare AS
Lifecare AS is a medical sensor company developing miniaturized and implantable nanobiosensors for continuous monitoring of glucose and other biomarkers. Its core technology, Sencell, is designed for use in human and veterinary applications and is being developed through research, product validation, manufacturing scale-up, and regulatory preparation for commercial use.
Generate the Lifecare AS report
Lifecare AS is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.
Sources & methodology
Financial figures are sourced from Valuatum's financial model for Lifecare AS and represent the latest completed financial year (2025). See the methodology for the full Valuatum AI equity research framework.
Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.